Prime study : a randomised phase 3 study of panitumumab with Folfox4 versus Folfox4 alone as first line treatment for metastatic colorectal cancer (mCRC)

作者: Jennifer Gansert , Mario E. Barugel , James Cassidy , David Cunningham , Josef Tabernero

DOI:

关键词:

摘要:

参考文章(0)